Debra L. Zynger

3.1k total citations
88 papers, 2.0k citations indexed

About

Debra L. Zynger is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Debra L. Zynger has authored 88 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Surgery, 33 papers in Pulmonary and Respiratory Medicine and 20 papers in Molecular Biology. Recurrent topics in Debra L. Zynger's work include Bladder and Urothelial Cancer Treatments (18 papers), Urologic and reproductive health conditions (15 papers) and Renal cell carcinoma treatment (13 papers). Debra L. Zynger is often cited by papers focused on Bladder and Urothelial Cancer Treatments (18 papers), Urologic and reproductive health conditions (15 papers) and Renal cell carcinoma treatment (13 papers). Debra L. Zynger collaborates with scholars based in United States, Germany and France. Debra L. Zynger's co-authors include Ximing J. Yang, Gary Tozbikian, Chunyan Luan, Pauline M. Chou, Wei Rao, Shuting Zhao, Michael V. Knopp, Xiaoming He, Xiongbin Lu and Zarine K. Shah and has published in prestigious journals such as Journal of Clinical Oncology, The EMBO Journal and ACS Nano.

In The Last Decade

Debra L. Zynger

87 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debra L. Zynger United States 24 558 540 519 442 351 88 2.0k
Yanling Ma United States 28 609 1.1× 766 1.4× 909 1.8× 762 1.7× 385 1.1× 100 2.7k
Melinda M. Lewis United States 17 603 1.1× 280 0.5× 394 0.8× 407 0.9× 178 0.5× 38 1.6k
Johannes S. de Jong Netherlands 13 635 1.1× 613 1.1× 435 0.8× 626 1.4× 420 1.2× 14 2.5k
Changjing Zuo China 23 289 0.5× 485 0.9× 399 0.8× 457 1.0× 343 1.0× 137 2.1k
Shengming Deng China 21 487 0.9× 407 0.8× 251 0.5× 860 1.9× 497 1.4× 82 1.9k
Rick G. Pleijhuis Netherlands 15 435 0.8× 541 1.0× 406 0.8× 433 1.0× 591 1.7× 30 2.5k
Robert A. Fenstermaker United States 35 1.3k 2.4× 383 0.7× 270 0.5× 718 1.6× 632 1.8× 132 3.5k
José A. Hardillo Netherlands 25 335 0.6× 477 0.9× 792 1.5× 499 1.1× 241 0.7× 96 2.1k
Henriëtte J.G. Arts Netherlands 24 591 1.1× 583 1.1× 1.3k 2.5× 705 1.6× 381 1.1× 48 3.9k
Wendy Kelder Netherlands 15 393 0.7× 471 0.9× 387 0.7× 548 1.2× 304 0.9× 31 2.2k

Countries citing papers authored by Debra L. Zynger

Since Specialization
Citations

This map shows the geographic impact of Debra L. Zynger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra L. Zynger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra L. Zynger more than expected).

Fields of papers citing papers by Debra L. Zynger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra L. Zynger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra L. Zynger. The network helps show where Debra L. Zynger may publish in the future.

Co-authorship network of co-authors of Debra L. Zynger

This figure shows the co-authorship network connecting the top 25 collaborators of Debra L. Zynger. A scholar is included among the top collaborators of Debra L. Zynger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra L. Zynger. Debra L. Zynger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zynger, Debra L., et al.. (2019). Impact of the 2018 ASCO/CAP HER2 Guideline Focused Update. American Journal of Clinical Pathology. 152(1). 17–26. 35 indexed citations
2.
Tozbikian, Gary & Debra L. Zynger. (2018). HER2 equivocal breast cancer that is positive by alternative probe HER2 FISH are classified as HER2 negative by Oncotype DX. The Breast Journal. 24(4). 535–540. 2 indexed citations
3.
4.
Zynger, Debra L., et al.. (2017). von Brunn's Nests and Follicular Cystitis Following Intradetrusor OnabotulinumtoxinA Injections for Overactive Bladder. Urology Case Reports. 14. 38–41. 1 indexed citations
5.
Petros, Firas G., Debra L. Zynger, Geoffrey N. Box, & Ketul Shah. (2016). Perinephric Hematoma and Hemorrhagic Shock as a Rare Presentation for an Acutely Obstructive Ureteral Stone with Forniceal Rupture: A Case Report. Journal of Endourology Case Reports. 2(1). 74–77. 3 indexed citations
6.
Tozbikian, Gary, et al.. (2016). Breast cancer biomarkers before and after neoadjuvant chemotherapy: does repeat testing impact therapeutic management?. Human Pathology. 62. 215–221. 27 indexed citations
7.
Zhang, Jianying, et al.. (2016). Impact of the 2013 ASCO/CAP HER2 revised guidelines on HER2 results in breast core biopsies with invasive breast carcinoma: a retrospective study. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 469(2). 203–212. 9 indexed citations
8.
9.
Chen, Zhong, Xun Lan, Jennifer M. Thomas‐Ahner, et al.. (2014). Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer. The EMBO Journal. 34(4). 502–516. 67 indexed citations
10.
11.
Wang, Chao, Thierry Pécot, Debra L. Zynger, et al.. (2013). Identifying survival associated morphological features of triple negative breast cancer using multiple datasets. Journal of the American Medical Informatics Association. 20(4). 680–687. 36 indexed citations
12.
13.
Zynger, Debra L., et al.. (2013). Histologic Impact of Dual-modality Intracorporeal Lithotripters to the Renal Pelvis. Urology. 82(1). 27–32. 2 indexed citations
14.
Shabsigh, Ahmad, et al.. (2012). Sclerosing Sertoli cell tumor without expression of typical sex cord stromal tumor markers: Case report and literature review. Pathology - Research and Practice. 208(2). 121–125. 11 indexed citations
15.
Zhang, Chunpeng, Liguo Wang, Dayong Wu, et al.. (2011). Definition of a FoxA1 Cistrome That Is Crucial for G1 to S-Phase Cell-Cycle Transit in Castration-Resistant Prostate Cancer. Cancer Research. 71(21). 6738–6748. 73 indexed citations
16.
Jia, Guang, Ronney Abaza, Debra L. Zynger, et al.. (2011). Amide proton transfer MR imaging of prostate cancer: A preliminary study. Journal of Magnetic Resonance Imaging. 33(3). 647–654. 155 indexed citations
17.
Zynger, Debra L. & Ximing J. Yang. (2009). High-grade prostatic intraepithelial neoplasia of the prostate: the precursor lesion of prostate cancer.. PubMed. 2(4). 327–38. 23 indexed citations
18.
Pearlman, Aaron N., et al.. (2009). Localized amyloidosis of the nasal and paranasal mucosa: a rare pathology. American Journal of Otolaryngology. 31(2). 130–131. 8 indexed citations
19.
Sasaki, Kotaro, Sheldon Bastacky, Debra L. Zynger, & Anil V. Parwani. (2009). Use of Immunohistochemical Markers to Confirm the Presence of Vas Deferens in Vasectomy Specimens. American Journal of Clinical Pathology. 132(6). 893–898. 9 indexed citations
20.
Schweizer, J., Debra L. Zynger, & Uta Francke. (1999). In vivo Nuclease Hypersensitivity Studies Reveal Multiple Sites of Parental Origin-Dependent Differential Chromatin Conformation in the 150 Kb SNRPN Transcription Unit. Human Molecular Genetics. 8(4). 555–566. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanling Ma Breakdown of academic impact, for papers by Melinda M. Lewis Breakdown of academic impact, for papers by Johannes S. de Jong Breakdown of academic impact, for papers by Changjing Zuo Breakdown of academic impact, for papers by Shengming Deng Breakdown of academic impact, for papers by Rick G. Pleijhuis Breakdown of academic impact, for papers by Robert A. Fenstermaker Breakdown of academic impact, for papers by José A. Hardillo Breakdown of academic impact, for papers by Henriëtte J.G. Arts Breakdown of academic impact, for papers by Wendy Kelder
Rankless by CCL
2026